Keywords

Bone cancer

Breast Cancer

General Oncology

Gynecological Cancers

Head and neck cancer

Lung Cancer

Radiation Oncology

A Rare impact of Cyclophosphamide induced Acute opening Pneumonitis: A Case Report

Correspondence to Author: Situmo Zhang, 

First Affiliated Hospital of Peking University, China

Abstract:

A 41-year-old patient with pathological process carcinoma suffered from pneumonitis once administration of cyclophosphamide. A CT angiogram with IV distinction was compatible with pneumonia and it had been treated with broad spectrum antibiotics. different causes of pneumonic unwellness were dominated out terminal patient developed cyclophosphamide induced inflammation. Thus, a lot of attention is required to the intense and rare aspect effects of cyclophosphamide related respiratory organ toxicities. during this case report, we’ll target the rare side effects like cyclophosphamide-induced inflammation (AIP) occurring in but 1 Chronicles of the population.

Citation:

Situmo Zhang. A Rare impact of Cyclophosphamide induced Acute opening Pneumonitis: A Case Report. World Journal of Medical Oncology 2020.

Journal Info

  • Journal Name: World Journal of Medical Oncology
  • Impact Factor: 2.709**
  • ISSN: 2766-6077
  • DOI: 10.52338/wjoncgy
  • Short Name: WJMOY
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days

INDEXING

  • Crossref indexed journal impact factor of 2.980**
  • Publons indexed journal impact factor of 3.90**
  • Pubmed-indexed journal impact factor of 5.2**
  • International Scientific Indexing (ISI)-indexed journal impact factor of 2.980**
  • Eurasian Scientific Journal Index (ESJI) index journal impact factor of 2.980**
  • Semantic Scholar indexed journal impact factor of 2.980**
  • Cosmos indexed journal impact factor of 3.981**

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility